BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 18776939)

  • 1. TNF-alpha and TLR agonists increase susceptibility to HIV-1 transmission by human Langerhans cells ex vivo.
    de Jong MA; de Witte L; Oudhoff MJ; Gringhuis SI; Gallay P; Geijtenbeek TB
    J Clin Invest; 2008 Oct; 118(10):3440-52. PubMed ID: 18776939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human immature Langerhans cells restrict CXCR4-using HIV-1 transmission.
    Sarrami-Forooshani R; Mesman AW; van Teijlingen NH; Sprokholt JK; van der Vlist M; Ribeiro CM; Geijtenbeek TB
    Retrovirology; 2014 Jul; 11():52. PubMed ID: 24990163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gram-positive bacteria enhance HIV-1 susceptibility in Langerhans cells, but not in dendritic cells, via Toll-like receptor activation.
    Ogawa Y; Kawamura T; Kimura T; Ito M; Blauvelt A; Shimada S
    Blood; 2009 May; 113(21):5157-66. PubMed ID: 19279330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIV-1 exposure and immune activation enhance sexual transmission of Hepatitis C virus by primary Langerhans cells.
    Nijmeijer BM; Sarrami-Forooshani R; Steba GS; Schreurs RR; Koekkoek SM; Molenkamp R; Schinkel J; Reiss P; Siegenbeek van Heukelom ML; van der Valk M; Ribeiro CM; Geijtenbeek TB
    J Int AIDS Soc; 2019 Mar; 22(3):e25268. PubMed ID: 30932366
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Herpes simplex virus type 2 enhances HIV-1 susceptibility by affecting Langerhans cell function.
    de Jong MA; de Witte L; Taylor ME; Geijtenbeek TB
    J Immunol; 2010 Aug; 185(3):1633-41. PubMed ID: 20592277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human immunodeficiency virus-1 acquisition in genital mucosa: Langerhans cells as key-players.
    de Jong MA; Geijtenbeek TB
    J Intern Med; 2009 Jan; 265(1):18-28. PubMed ID: 19093957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antimicrobial peptide LL-37 produced by HSV-2-infected keratinocytes enhances HIV infection of Langerhans cells.
    Ogawa Y; Kawamura T; Matsuzawa T; Aoki R; Gee P; Yamashita A; Moriishi K; Yamasaki K; Koyanagi Y; Blauvelt A; Shimada S
    Cell Host Microbe; 2013 Jan; 13(1):77-86. PubMed ID: 23332157
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Candidate microbicides block HIV-1 infection of human immature Langerhans cells within epithelial tissue explants.
    Kawamura T; Cohen SS; Borris DL; Aquilino EA; Glushakova S; Margolis LB; Orenstein JM; Offord RE; Neurath AR; Blauvelt A
    J Exp Med; 2000 Nov; 192(10):1491-500. PubMed ID: 11085750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pseudotyping of HIV-1 with Human T-Lymphotropic Virus 1 (HTLV-1) Envelope Glycoprotein during HIV-1-HTLV-1 Coinfection Facilitates Direct HIV-1 Infection of Female Genital Epithelial Cells: Implications for Sexual Transmission of HIV-1.
    Tang Y; George AM; Petrechko O; Nouvet FJ; Sweet SD; Tanaka Y; Imbiakha BS; Jiang G; Gao W; Anastos K; Hildreth JEK
    mSphere; 2018 Apr; 3(2):. PubMed ID: 29624497
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutz-3-derived Langerhans cells are a model to study HIV-1 transmission and potential inhibitors.
    de Jong MA; de Witte L; Santegoets SJ; Fluitsma D; Taylor ME; de Gruijl TD; Geijtenbeek TB
    J Leukoc Biol; 2010 Apr; 87(4):637-43. PubMed ID: 20042470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of cyclooxygenase (COX)-2 in human vaginal epithelial cells in response to TLR ligands and TNF-α.
    Joseph T; Zalenskaya IA; Yousefieh N; Schriver SD; Cote LC; Chandra N; Doncel GF
    Am J Reprod Immunol; 2012 Jun; 67(6):482-90. PubMed ID: 22235849
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Syndecan 4 Upregulation on Activated Langerhans Cells Counteracts Langerin Restriction to Facilitate Hepatitis C Virus Transmission.
    Nijmeijer BM; Eder J; Langedijk CJM; Kaptein TM; Meeussen S; Zimmermann P; Ribeiro CMS; Geijtenbeek TBH
    Front Immunol; 2020; 11():503. PubMed ID: 32292405
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor necrosis factor-alpha and interleukin-17 differently affects Langerhans cell distribution and activation in an innovative three-dimensional model of normal human skin.
    Prignano F; Arnaboldi F; Cornaghi L; Landoni F; Tripo L; Preis FW; Donetti E
    Eur J Cell Biol; 2015 Feb; 94(2):71-7. PubMed ID: 25596626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune activation of vaginal human Langerhans cells increases susceptibility to HIV-1 infection.
    van Teijlingen NH; Eder J; Sarrami-Forooshani R; Zijlstra-Willems EM; Roovers JWR; van Leeuwen E; Ribeiro CMS; Geijtenbeek TBH
    Sci Rep; 2023 Feb; 13(1):3283. PubMed ID: 36841916
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Langerhans cell and HIV.
    Kawamura T
    Nihon Rinsho Meneki Gakkai Kaishi; 2011; 34(2):70-5. PubMed ID: 21628848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calcitonin Gene-Related Peptide Induces HIV-1 Proteasomal Degradation in Mucosal Langerhans Cells.
    Bomsel M; Ganor Y
    J Virol; 2017 Dec; 91(23):. PubMed ID: 28904199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Herpes simplex virus type 2-infected dendritic cells produce TNF-α, which enhances CCR5 expression and stimulates HIV production from adjacent infected cells.
    Marsden V; Donaghy H; Bertram KM; Harman AN; Nasr N; Keoshkerian E; Merten S; Lloyd AR; Cunningham AL
    J Immunol; 2015 May; 194(9):4438-45. PubMed ID: 25840914
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV-1 transmission in the male genital tract.
    Ganor Y; Bomsel M
    Am J Reprod Immunol; 2011 Mar; 65(3):284-91. PubMed ID: 21114566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaginal langerhans cells nonproductively transporting HIV-1 mediate infection of T cells.
    Ballweber L; Robinson B; Kreger A; Fialkow M; Lentz G; McElrath MJ; Hladik F
    J Virol; 2011 Dec; 85(24):13443-7. PubMed ID: 21976645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human Langerhans cells selectively activated via Toll-like receptor 2 agonists acquire migratory and CD4+T cell stimulatory capacity.
    Peiser M; Koeck J; Kirschning CJ; Wittig B; Wanner R
    J Leukoc Biol; 2008 May; 83(5):1118-27. PubMed ID: 18252867
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.